PUB - Publikationen an der Universität Bielefeld

Immune cell promotion of metastasis.
Kitamura T, Qian BZ, Pollard JW., Nat. Rev. Immunol. 15(2), 2015
PMID: 25614318

Glycosylation in cancer: mechanisms and clinical implications.
Pinho SS, Reis CA., Nat. Rev. Cancer 15(9), 2015
PMID: 26289314

O-linked glycosylation in the mammary gland: changes that occur during malignancy.
Burchell JM, Mungul A, Taylor-Papadimitriou J., J Mammary Gland Biol Neoplasia 6(3), 2001
PMID: 11547903

Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.
Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani EN, Wilson D., J. Biol. Chem. 265(25), 1990
PMID: 1697589

An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
Burchell J, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D, Taylor-Papadimitriou J., Glycobiology 9(12), 1999
PMID: 10561455

Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.
Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J., J. Biol. Chem. 271(52), 1996
PMID: 8969192

The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell HH, Clausen H, Mandel U, Taylor-Papadimitriou J, Sletmoen M, Burchell JM., PLoS ONE 10(5), 2015
PMID: 25951175

Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Mungul A, Cooper L, Brockhausen I, Ryder K, Mandel U, Clausen H, Rughetti A, Miles DW, Taylor-Papadimitriou J, Burchell JM., Int. J. Oncol. 25(4), 2004
PMID: 15375543

Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, Mandel U, Dell A, Pinder S, Taylor-Papadimitriou J, Burchell J., Glycobiology 20(10), 2010
PMID: 20534593

Siglec-mediated regulation of immune cell function in disease.
Macauley MS, Crocker PR, Paulson JC., Nat. Rev. Immunol. 14(10), 2014
PMID: 25234143

The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T, Floyd H, Lopez F, Vivier E, Crocker PR., J. Immunol. 173(11), 2004
PMID: 15557178

Siglecs and their roles in the immune system.
Crocker PR, Paulson JC, Varki A., Nat. Rev. Immunol. 7(4), 2007
PMID: 17380156

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Demoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Munz C, von Gunten S., J. Clin. Invest. 124(4), 2014
PMID: 24569453

Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Laubli H, Pearce OM, Schwarz F, Siddiqui SS, Deng L, Stanczak MA, Deng L, Verhagen A, Secrest P, Lusk C, Schwartz AG, Varki NM, Bui JD, Varki A., Proc. Natl. Acad. Sci. U.S.A. 111(39), 2014
PMID: 25225409

Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.
Hudak JE, Canham SM, Bertozzi CR., Nat. Chem. Biol. 10(1), 2013
PMID: 24292068

Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
Tanida S, Akita K, Ishida A, Mori Y, Toda M, Inoue M, Ohta M, Yashiro M, Sawada T, Hirakawa K, Nakada H., J. Biol. Chem. 288(44), 2013
PMID: 24045940

Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Backstrom M, Link T, Olson FJ, Karlsson H, Graham R, Picco G, Burchell J, Taylor-Papadimitriou J, Noll T, Hansson GC., Biochem. J. 376(Pt 3), 2003
PMID: 12950230

Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.
Zhang JQ, Nicoll G, Jones C, Crocker PR., J. Biol. Chem. 275(29), 2000
PMID: 10801862

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
Dalziel M, Whitehouse C, McFarlane I, Brockhausen I, Gschmeissner S, Schwientek T, Clausen H, Burchell JM, Taylor-Papadimitriou J., J. Biol. Chem. 276(14), 2000
PMID: 11118434

Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A., Blood 113(14), 2009
PMID: 19196661

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW., Nature 475(7355), 2011
PMID: 21654748

Plasminogen activator inhibitor-1 regulates infiltration of macrophages into melanoma via phosphorylation of FAK-Tyr⁹²⁵.
Thapa B, Koo BH, Kim YH, Kwon HJ, Kim DS., Biochem. Biophys. Res. Commun. 450(4), 2014
PMID: 25063025

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis.
McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA., J. Biol. Chem. 276(36), 2001
PMID: 11441025

Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.
Bauerle KT, Schweppe RE, Lund G, Kotnis G, Deep G, Agarwal R, Pozdeyev N, Wood WM, Haugen BR., J. Clin. Endocrinol. Metab. 99(8), 2014
PMID: 24758177

Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis.
Chen H, Peng H, Liu W, Sun Y, Su N, Tang W, Zhang X, Wang J, Cui L, Hu P, Liu S., Surgery 158(6), 2015
PMID: 26275833

Environmental immune disruptors, inflammation and cancer risk.
Thompson PA, Khatami M, Baglole CJ, Sun J, Harris SA, Moon EY, Al-Mulla F, Al-Temaimi R, Brown DG, Colacci A, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Lowe L, Guarnieri T, Bisson WH., Carcinogenesis 36 Suppl 1(), 2015
PMID: 26106141

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.
Oosterhoff D, Lougheed S, van de Ven R, Lindenberg J, van Cruijsen H, Hiddingh L, Kroon J, van den Eertwegh AJ, Hangalapura B, Scheper RJ, de Gruijl TD., Oncoimmunology 1(5), 2012
PMID: 22934257

Nitric oxide synthase in innate and adaptive immunity: an update.
Bogdan C., Trends Immunol. 36(3), 2015
PMID: 25687683

Macrophage activation and polarization: nomenclature and experimental guidelines.
Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA., Immunity 41(1), 2014
PMID: 25035950

Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells.
Rughetti A, Pellicciotta I, Biffoni M, Backstrom M, Link T, Bennet EP, Clausen H, Noll T, Hansson GC, Burchell JM, Frati L, Taylor-Papadimitriou J, Nuti M., J. Immunol. 174(12), 2005
PMID: 15944279

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages; undisputed stars of the inflammatory tumour micrenvironment
Allavena P, Mantovani A., 2012

Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells.
Forouzandeh F, Jalili RB, Germain M, Duronio V, Ghahary A., Mol. Cell. Biochem. 309(1-2), 2007
PMID: 18008147

Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
Gianchecchi E, Delfino DV, Fierabracci A., Autoimmun Rev 12(11), 2013
PMID: 23792703

Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, Monkkonen J, Kellokumpu-Lehtinen PL, Lauttia S, Tynninen O, Joensuu H, Heymann D, Maatta JA., Breast Cancer Res. 17(), 2015
PMID: 26243145

Macrophage diversity enhances tumor progression and metastasis.
Qian BZ, Pollard JW., Cell 141(1), 2010
PMID: 20371344

Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.
Paul SP, Taylor LS, Stansbury EK, McVicar DW., Blood 96(2), 2000
PMID: 10887109

The functional contribution of calcium ion flux heterogeneity in T cells
Christo SN, Diener KR, Hayball JD., 2015

A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR., Proc. Natl. Acad. Sci. U.S.A. 92(17), 1995
PMID: 7644477

Tumor-associated macrophages are correlated with tamoxifen resistance in the postmenopausal breast cancer patients.
Xuan QJ, Wang JX, Nanding A, Wang ZP, Liu H, Lian X, Zhang QY., Pathol. Oncol. Res. 20(3), 2014
PMID: 24414992

Tumor-associated macrophages: from mechanisms to therapy.
Noy R, Pollard JW., Immunity 41(1), 2014
PMID: 25035953

Pembrolizumab for the treatment of non-small-cell lung cancer.
Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L; KEYNOTE-001 Investigators, Hui R, Chu Q, Leighl N, Chomy F, Dansin E, Lena H, Quere G, Soria JC, Cappuzzo F, Garassino M, Melotti B, Morabito A, Santini D, Brunsvig P, Flotten O, Ahn MJ, Lee DH, Lee JS, Carcereny E, Felip E, Insa A, Yang JC, Tsai CM, Arkenau HT, Grummet S, Middleton G, Aggarwal C, Balmanoukian AS, Bessudo A, Blumenschein GR Jr, Dronca R, Eder JP, Garon EB, Gandhi L, Goldman J, Gubens M, Hager S, Hamid O, Hellmann MD, Horn L, Johnson E, O'Day S, Patnaik A, Ramalingam S, Rizvi NA, Ross H, Socinski M., N. Engl. J. Med. 372(21), 2015
PMID: 25891174

MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gutgemann I, Eilers M, Felsher DW., Science 352(6282), 2016
PMID: 26966191

The blockade of immune checkpoints in cancer immunotherapy.
Pardoll DM., Nat. Rev. Cancer 12(4), 2012
PMID: 22437870

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.
Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A, Andre S, Gabius HJ, Rancourt C, Connor J, Paulson JC, Patankar MS., Mol. Cancer 9(), 2010
PMID: 20497550

Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9.
Ohta M, Ishida A, Toda M, Akita K, Inoue M, Yamashita K, Watanabe M, Murata T, Usui T, Nakada H., Biochem. Biophys. Res. Commun. 402(4), 2010
PMID: 20971061

Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1.
Correa I, Plunkett T, Coleman J, Galani E, Windmill E, Burchell JM, Taylor-Papdimitriou J., Int. J. Cancer 115(5), 2005
PMID: 15729696

The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.
Priatel JJ, Chui D, Hiraoka N, Simmons CJ, Richardson KB, Page DM, Fukuda M, Varki NM, Marth JD., Immunity 12(3), 2000
PMID: 10755614

Sialyl-Lewis(x) on P-selectin glycoprotein ligand-1 is regulated during differentiation and maturation of dendritic cells: a mechanism involving the glycosyltransferases C2GnT1 and ST3Gal I.
Julien S, Grimshaw MJ, Sutton-Smith M, Coleman J, Morris HR, Dell A, Taylor-Papadimitriou J, Burchell JM., J. Immunol. 179(9), 2007
PMID: 17947642

Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D, Julien S, Burford B, Taylor-Papadimitriou J, Burchell JM., J. Biol. Chem. 287(53), 2012
PMID: 23275522

Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations.
Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR., Blood 97(1), 2001
PMID: 11133773

Negative regulation of Toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33.
Ishida A, Akita K, Mori Y, Tanida S, Toda M, Inoue M, Nakada H., J. Biol. Chem. 289(36), 2014
PMID: 25059667

Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.
Varchetta S, Brunetta E, Roberto A, Mikulak J, Hudspeth KL, Mondelli MU, Mavilio D., PLoS ONE 7(9), 2012
PMID: 23029261

Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A., Blood 113(14), 2009
PMID: 19196661

Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis.
Tran TT, Poirier H, Clement L, Nassir F, Pelsers MM, Petit V, Degrace P, Monnot MC, Glatz JF, Abumrad NA, Besnard P, Niot I., J. Biol. Chem. 286(28), 2011
PMID: 21610069

Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
Allen MD, Thomas GJ, Clark S, Dawoud MM, Vallath S, Payne SJ, Gomm JJ, Dreger SA, Dickinson S, Edwards DR, Pennington CJ, Sestak I, Cuzick J, Marshall JF, Hart IR, Jones JL., Clin. Cancer Res. 20(2), 2013
PMID: 24150233

Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice.
Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML., Cell 74(1), 1993
PMID: 8334701

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
Mihara M, Kasutani K, Okazaki M, Nakamura A, Kawai S, Sugimoto M, Matsumoto Y, Ohsugi Y., Int. Immunopharmacol. 5(12), 2005
PMID: 16102523

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, Dronca R, Gangadhar TC, Patnaik A, Zarour H, Joshua AM, Gergich K, Elassaiss-Schaap J, Algazi A, Mateus C, Boasberg P, Tumeh PC, Chmielowski B, Ebbinghaus SW, Li XN, Kang SP, Ribas A., N. Engl. J. Med. 369(2), 2013
PMID: 23724846

Stearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblasts.
Angelucci C, Maulucci G, Colabianchi A, Iacopino F, D'Alessio A, Maiorana A, Palmieri V, Papi M, De Spirito M, Di Leone A, Masetti R, Sica G., Br. J. Cancer 112(10), 2015
PMID: 25880005

Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma.
Hengartner NE, Fiedler J, Schrezenmeier H, Huber-Lang M, Brenner RE., PLoS ONE 10(1), 2015
PMID: 25562599

Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
Chang TP, Poltoratsky V, Vancurova I., J. Immunol. 194(6), 2015
PMID: 25681335

NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
Zou Y, Bao J, Pan X, Lu Y, Liao S, Wang X, Wang G, Lin D., PLoS ONE 10(8), 2015
PMID: 26241657

CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
Hoyer JD, Grogg KL, Hanson CA, Gamez JD, Dogan A., Am. J. Clin. Pathol. 129(2), 2008
PMID: 18208813

The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T, Floyd H, Lopez F, Vivier E, Crocker PR., J. Immunol. 173(11), 2004
PMID: 15557178

Expression profiles of novel cell surface molecules on B-cell subsets and plasma cells as analyzed by flow cytometry.
Llinas L, Lazaro A, de Salort J, Matesanz-Isabel J, Sintes J, Engel P., Immunol. Lett. 134(2), 2010
PMID: 20951740

Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.
Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S., Blood 114(26), 2009
PMID: 19861682

CD14(+)HLA-DR(low/-) expression: A novel prognostic factor in chronic lymphocytic leukemia.
Liu J, Zhou Y, Huang Q, Qiu L., Oncol Lett 9(3), 2014
PMID: 25663875

A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
Perussia B, Fanning V, Trinchieri G., J. Immunol. 131(1), 1983
PMID: 6408172

Common variants in P2RY11 are associated with narcolepsy.
Kornum BR, Kawashima M, Faraco J, Lin L, Rico TJ, Hesselson S, Axtell RC, Kuipers H, Weiner K, Hamacher A, Kassack MU, Han F, Knudsen S, Li J, Dong X, Winkelmann J, Plazzi G, Nevsimalova S, Hong SC, Honda Y, Honda M, Hogl B, Ton TG, Montplaisir J, Bourgin P, Kemlink D, Huang YS, Warby S, Einen M, Eshragh JL, Miyagawa T, Desautels A, Ruppert E, Hesla PE, Poli F, Pizza F, Frauscher B, Jeong JH, Lee SP, Strohl KP, Longstreth WT Jr, Kvale M, Dobrovolna M, Ohayon MM, Nepom GT, Wichmann HE, Rouleau GA, Gieger C, Levinson DF, Gejman PV, Meitinger T, Peppard P, Young T, Jennum P, Steinman L, Tokunaga K, Kwok PY, Risch N, Hallmayer J, Mignot E., Nat. Genet. 43(1), 2010
PMID: 21170044

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
Spaan M, Hullegie SJ, Beudeker BJ, Kreefft K, van Oord GW, Groothuismink ZM, van Tilborg M, Rijnders B, de Knegt RJ, Claassen MA, Boonstra A., PLoS ONE 11(7), 2016
PMID: 27416100

Human autoreactive T cells recognize CD1b and phospholipids.
Van Rhijn I, van Berlo T, Hilmenyuk T, Cheng TY, Wolf BJ, Tatituri RV, Uldrich AP, Napolitani G, Cerundolo V, Altman JD, Willemsen P, Huang S, Rossjohn J, Besra GS, Brenner MB, Godfrey DI, Moody DB., Proc. Natl. Acad. Sci. U.S.A. 113(2), 2015
PMID: 26621732

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.
Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quevrain E, Bridonneau C, Preisser L, Asehnoune K, Labarriere N, Altare F, Sokol H, Jotereau F., PLoS Biol. 12(4), 2014
PMID: 24714093

Modulation of human immune responses by bovine interleukin-10.
den Hartog G, Savelkoul HF, Schoemaker R, Tijhaar E, Westphal AH, de Ruiter T, van de Weg-Schrijver E, van Neerven RJ., PLoS ONE 6(3), 2011
PMID: 21464967

T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine.
Weaver EA, Mercier GT, Gottschalk S, Barry MA., Mucosal Immunol 5(3), 2012
PMID: 22377931

CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages.
Ball MS, Shipman EP, Kim H, Liby KT, Pioli PA., PLoS ONE 11(2), 2016
PMID: 26918785

Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions.
Kostic I, Fidalgo-Carvalho I, Aday S, Vazao H, Carvalheiro T, Graos M, Duarte A, Cardoso C, Goncalves L, Carvalho L, Paiva A, Ferreira L., Sci Rep 5(), 2015
PMID: 26553339

Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways.
Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R, Clementi E, Bianchi ME, Cossu G, Manfredi AA, Brunelli S, Rovere-Querini P., J. Leukoc. Biol. 85(5), 2009
PMID: 19197071

Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.
Jutz S, Leitner J, Schmetterer K, Doel-Perez I, Majdic O, Grabmeier-Pfistershammer K, Paster W, Huppa JB, Steinberger P., J. Immunol. Methods 430(), 2016
PMID: 26780292

The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
Berry N, Jones DB, Smallwood J, Taylor I, Kirkham N, Taylor-Papadimitriou J., Br. J. Cancer 51(2), 1985
PMID: 2578285

CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling.
Strauss G, Lindquist JA, Arhel N, Felder E, Karl S, Haas TL, Fulda S, Walczak H, Kirchhoff F, Debatin KM., J. Exp. Med. 206(6), 2009
PMID: 19487421

Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions.
Abbonante V, Gruppi C, Rubel D, Gross O, Moratti R, Balduini A., J. Biol. Chem. 288(23), 2013
PMID: 23530036

AUTHOR UNKNOWN, 0